下一个

自动播放

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

2 意见 • 08/04/23
分享
嵌入
administrator
administrator
订户
0

Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放